- Health
- By Laura Sinpetru
- January 8th, 2013
New Lilly, Boehringer Diabetes Drug Performs Well in Trial
Empagliflozin, a treatment for type 2 diabetes, managed to lower blood sugar levels
Empagliflozin, a treatment for type 2 diabetes, managed to lower blood sugar levels